I have been talking about how oversold so much of the small biotech and biophama space has become for several monthsAfter a once-in-a-generation selloff, there literally are several hundred small biotech stocks that sell at or less than the net cash on their balance sheetsThe action in this space reminds me of how small tech stocks were trading at...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.